A Study Of TL-925 For The Treatment of AC

Conditions: Allergic Conjunctivitis Interventions: Drug: TL-925; Drug: Placebo Sponsors: Telios Pharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials